Zimbabwe has declined a significant American health deal worth $367m (272 million pounds) spanning five years due to the United States' insistence on confidential biological samples.
This move came to light following a internal memorandum dated December was leaked, which showed Head of State Emmerson Mnangagwa felt the arrangement was "skewed".
A government representative later explained that the US was seeking biological samples for research and commercial gain but refused to guarantee the benefits from future vaccines.
"We must now begin the difficult and regrettable task of winding down our health aid in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy indicated the US had donated more than $1.9bn for health programmes to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has appealed for further negotiations to secure a deal agreeable to both sides so the nation's vital HIV treatment initiative can proceed.
Wider Background
This rejection follows a comparable case in Kenya, where a court suspended a related health funding agreement after concerns were filed about the safety of Kenyans' health data.
Since returning to office last year, US President Donald Trump has reduced overseas assistance and shut down the US Agency for International Development (USAID).
USAID had administered assistance for the American government, but Trump argued its expenditure was "wasteful" and his government was pursuing direct bilateral agreements to enhance transparency and responsibility.
According to reports, Sixteen African countries have to date signed these new health pacts, representing over $18.3bn in committed funds.
Details of the Declined Agreement
The money for Zimbabwe was intended to supported "combating HIV/Aids, TB, malaria, maternal and child health, and preparing for epidemics".
"It is our view this cooperation would have delivered significant advantages for Zimbabwean communities, particularly the 1.2 million presently on HIV treatment via American-funded programmes," the Ambassador added.
However, official spokesman Nick Mangwana said the arrangement was "asymmetrical".
"Our nation was requested to surrender its biological resources and data indefinitely, with no equivalent guarantee of benefiting from any scientific breakthroughs – such as new medicines or tests – that could be developed from that shared data," his statement read.
"Put simply, our country would provide the basic resources for medical research without any assurance that the resulting innovations would be available to our population should a new disease outbreak arise."
National Interest and Global Health
He also pointed out that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one deals were upending structures already established via the global organization.
Mangwana cited its Pathogen Access and Benefit Sharing framework created to deal with potential global health emergencies.
"This system is intended to ensure that when a nation contributes its data, the benefits – including medicines and cures – are distributed fairly, not commercialised solely by those with the capability to create them."
The government's concerns regarding the US deal "must not be interpreted as hostility towards the US," Mangwana stressed.
"We encourage continued discussions with our US partners on how subsequent collaboration might be structured in a way that respects the sovereignty and interests of each country."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it recognised the government's concerns, but suggested that negotiations must proceed considering much of the country's HIV programmes depended on international support.
"Where specific concerns exist, including those relating to data governance or agreement terms, these can often be addressed through technical clarification and mutually agreed protections," the group said.
This impasse highlights the complex tensions between accepting much-needed international aid and protecting national sovereignty in an increasingly interconnected world.